Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Nemus Bioscience has picked the controlled-substance manufacturing specialist Noramco to scale up production of cannabidiol-valine-hemisuccinate, a cannabidiol analog Nemus licensed from the University of Mississippi. The biotech firm says the analog is more bioavailable than cannabidiol as a treatment for ocular diseases. Meanwhile, Nemus hopes this year to begin clinical trials of a related product, tetrahydrocannabinol-valine-hemisuccinate, licensed from UM and produced by Albany Molecular Research for treating glaucoma.
This article has been sent to the following recipient: